Increased phosphotyrosine content and inhibition of proliferation in EGF-treated A431 cells

来自 EBSCO

阅读量：

作者：

展开

摘要：

Epidermal growth factor (EGF), which binds to specific high-affinity cell-surface receptors, stimulates replication of a number of cell types 1,2 . In vitro EGF stimulates a membrane-associated protein kinase which catalyses phosphorylation of the EGF receptor at tyrosine residues 3,4 . The transforming proteins of several RNA tumour viruses are protein kinases which also specifically catalyse phosphorylation at tyrosine residues 5–10 . An elevated level of phosphotyrosine is found in cells transformed by Rous sarcoma, Fujinami sarcoma, PRCII, Y73, Snyder–Theilin and Gardner–Armstrong feline sarcoma and Abelson murine leukaemia viruses 5,10–12 . At least four of these viruses, which encode distinct protein kinases, catalyse phosphorylation of tyrosine residues in the same cellular substrate proteins 13 . In vitro EGF-stimulated protein kinase catalyses the phosphorylation of anti-p60 src heavy chains, suggesting that this enzyme recognizes similar substrate determinants to p60 src (refs 14,15). Here we demonstrate that EGF treatment of A431 human epidermoid carcinoma cells increases phosphotyrosine content, indicating that EGF stimulates tyro sine-specific protein kinase activity in vivo as well as in vitro . In contrast to Rous sarcoma virus (RSV) transformation, EGF inhibits replication of A431 cells. This inhibition by EGF is influenced by both cell density and tissue culture substratum.

展开

关键词：

Humans Cell Line Carcinoma, Squamous Cell Protein Kinases Receptor, Epidermal Growth Factor Receptors, Cell Surface Cell Division Contact Inhibition Epidermal Growth Factor